Publications – 2009

  • Januzzi JL Jr. Troponin testing after cardiac surgery. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1(3):22-32.
  • Bangalore S, Mauri L. Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds?. EuroIntervention. 2009 Dec 15;5 Suppl F:F43-8. doi: 10.4244/EIJV5IFA7.
  • Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC Cardiovasc Interv. 2009 Dec;2(12):1269-75. doi: 10.1016/j.jcin.2009.10.005.
  • Ellis SG, Stone GW, Cox DA, Hermiller J, O’Shaughnessy C, Mann T, Turco M, Caputo R, Bergin PJ, Bowman TS, Baim DS; TAXUS IV Investigators. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent). JACC Cardiovasc Interv. 2009 Dec;2(12):1248-59. doi: 10.1016/j.jcin.2009.10.003.
  • Leon MB, Kandzari DE, Eisenstein EL, Anstrom KJ, Mauri L, Cutlip DE, Nikolsky E, O’Shaughnessy C, Overlie PA, Kirtane AJ, McLaurin BT, Solomon SL, Douglas JS Jr, Popma JJ; ENDEAVOR IV Investigators. Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2009 Dec;2(12):1208-18. doi: 10.1016/j.jcin.2009.10.008.
  • Murphy SA, Cannon CP, Wiviott SD, McCabe CH, Braunwald E. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial. J Am Coll Cardiol. 2009 Dec 15;54(25):2358-62. doi: 10.1016/j.jacc.2009.10.005.
  • Truong QA, Siegel E, Cannon CP. Cardiac CT angiography–radiation dose-how effective are we in reducing radiation dose from cardiac CT angiography?. Rev Cardiovasc Med. 2009 Fall;10(4):236-9.
  • Mohammed AA, Januzzi JL Jr. The emerging role of highly sensitive troponin in the evaluation of acute coronary syndrome. Compr Ther. 2009 Fall-Winter;35(3-4):167-76.
  • Lewis WR, Ellrodt AG, Peterson E, Hernandez AF, LaBresh KA, Cannon CP, Pan W, Fonarow GC. Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program. Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):633-41. doi: 10.1161/CIRCOUTCOMES.108.824763. Epub 2009 Oct 27.
  • Pride YB, Canto JG, Frederick PD, Gibson CM; NRMI Investigators. Outcomes among patients with ST-segment-elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery. Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):574-82. doi: 10.1161/CIRCOUTCOMES.108.841296. Epub 2009 Nov 3.
  • Peterson ED, Roe MT, Rumsfeld JS, Shaw RE, Brindis RG, Fonarow GC, Cannon CP. A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):491-9. doi: 10.1161/CIRCOUTCOMES.108.847145.
  • Roe MT, Chen AY, Cannon CP, Rao S, Rumsfeld J, Magid DJ, Brindis R, Klein LW, Gibler WB, Ohman EM, Peterson ED; CRUSADE and ACTION-GWTG Registry Participants. Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):414-20. doi: 10.1161/CIRCOUTCOMES.109.850248. Epub 2009 Jul 28.
  • Lasala JM, Cox DA, Dobies D, Baran K, Bachinsky WB, Rogers EW, Breall JA, Lewis DH, Song A, Starzyk RM, Mascioli SR, Dawkins KD, Baim DS; ARRIVE 1 and ARRIVE 2 Participating Physicians. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries. Circ Cardiovasc Interv. 2009 Aug;2(4):285-93. doi: 10.1161/CIRCINTERVENTIONS.109.852178.109.852178. Epub 2009 Jul 22.
  • Forman DE, Cox DA, Ellis SG, Lasala JM, Ormiston JA, Stone GW, Turco MA, Wei JY, Joshi AA, Dawkins KD, Baim DS. Long-term paclitaxel-eluting stent outcomes in elderly patients. Circ Cardiovasc Interv. 2009 Jun;2(3):178-87. doi: 10.1161/CIRCINTERVENTIONS.109.855221. Epub 2009 Jun 2.
  • Popma JJ, Mauri L, O’Shaughnessy C, Overlie P, McLaurin B, Almonacid A, Kirtane A, Leon MB. Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents. Circ Cardiovasc Interv. 2009 Apr;2(2):133-9. doi: 10.1161/CIRCINTERVENTIONS.108.832048. Epub 2009 Apr 1.
  • Tcheng JE, Lim IH, Srinivasan S, Jozic J, Gibson CM, O’Shea JC, Puma JA, Simon DI. Stent parameters predict major adverse clinical events and the response to platelet glycoprotein IIb/IIIa blockade: findings of the ESPRIT trial. Circ Cardiovasc Interv. 2009 Feb;2(1):43-51. doi: 10.1161/CIRCINTERVENTIONS.108.809285. Epub 2008 Dec 3.
  • Singh M, Peterson ED, Roe MT, Ou FS, Spertus JA, Rumsfeld JS, Anderson HV, Klein LW, Ho KK, Holmes DR. Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience. Circ Cardiovasc Interv. 2009 Feb;2(1):20-6. doi: 10.1161/CIRCINTERVENTIONS.108.826172. Epub 2009 Feb 10.
  • Rose SA, Turchin A, Grant RW, Meigs JB. Documentation of body mass index and control of associated risk factors in a large primary care network. BMC Health Serv Res. 2009 Dec 16;9:236. doi: 10.1186/1472-6963-9-236.
  • Miller MA, Elmariah S, Fischer A. Giant T-wave inversions and extreme QT prolongation. Circ Arrhythm Electrophysiol. 2009 Dec;2(6):e42-3. doi: 10.1161/CIRCEP.108.825729.
  • Gibson CM, Pride YB, Hochberg CP, Sloan S, Sabatine MS, Cannon CP; TIMI Study Group. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy. J Am Coll Cardiol. 2009 Dec 8;54(24):2290-5. doi: 10.1016/j.jacc.2009.09.010.
  • Meadows TA, Bhatt DL, Hirsch AT, Creager MA, Califf RM, Ohman EM, Cannon CP, Eagle KA, Alberts MJ, Goto S, Smith SC Jr, Wilson PW, Watson KE, Steg PG; REACH Registry Investigators. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. Am Heart J. 2009 Dec;158(6):1038-45. doi: 10.1016/j.ahj.2009.09.014.
  • Berger JS, Roe MT, Gibson CM, Kilaru R, Green CL, Melton L, Blankenship JD, Metzger DC, Granger CB, Gretler DD, Grines CL, Huber K, Zeymer U, Buszman P, Harrington RA, Armstrong PW. Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial. Am Heart J. 2009 Dec;158(6):998-1004.e1. doi: 10.1016/j.ahj.2009.10.010.
  • Rao SV, Eikelboom J, Steg PG, Lincoff AM, Weintraub WS, Bassand JP, Rao AK, Gibson CM, Petersen JL, Mehran R, Manoukian SV, Charnigo R, Lee KL, Moscucci M, Harrington RA; Academic Bleeding Consensus Multidisciplinary Working Group. Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group. Am Heart J. 2009 Dec;158(6):881-886.e1. doi: 10.1016/j.ahj.2009.10.008.
  • Cole A, Nathan DM, Savaria-Porter E, Copeland P, Turchin A, Brunt M, Zusman R, Barrett JA, Wexler D, Case E, McMahon GT, Mort E. An algorithm for the care of type 2 diabetes. Crit Pathw Cardiol. 2009 Dec;8(4):156-65. doi: 10.1097/HPC.0b013e3181c017e2.
  • Bhardwaj A, Januzzi JL Jr. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm. Crit Pathw Cardiol. 2009 Dec;8(4):146-50. doi: 10.1097/HPC.0b013e3181c4a0c6.
  • Vasan RS, Pencina MJ, Robins SJ, Zachariah JP, Kaur G, D’Agostino RB, Ordovas JM. Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community. Circulation. 2009 Dec 15;120(24):2414-20. doi: 10.1161/CIRCULATIONAHA.109.872705.
  • Kumbhani DJ, Cannon CP, Fonarow GC, Liang L, Askari AT, Peacock WF, Peterson ED, Bhatt DL; Get With the Guidelines Steering Committee and Investigators. Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. JAMA. 2009 Nov 25;302(20):2207-13. doi: 10.1001/jama.2009.1715.
  • Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ; EVENT Registry Investigators. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry. JACC Cardiovasc Interv. 2009 Nov;2(11):1074-82. doi: 10.1016/j.jcin.2009.09.002.
  • Bhatt DL, Lincoff AM, Gibson CM, Stone GW, McNulty S, Montalescot G, Kleiman NS, Goodman SG, White HD, Mahaffey KW, Pollack CV Jr, Manoukian SV, Widimsky P, Chew DP, Cura F, Manukov I, Tousek F, Jafar MZ, Arneja J, Skerjanec S, Harrington RA; CHAMPION PLATFORM Investigators. Intravenous platelet blockade with cangrelor during PCI. N Engl J Med. 2009 Dec 10;361(24):2330-41. doi: 10.1056/NEJMoa0908629.
  • Harrington RA, Stone GW, McNulty S, White HD, Lincoff AM, Gibson CM, Pollack CV Jr, Montalescot G, Mahaffey KW, Kleiman NS, Goodman SG, Amine M, Angiolillo DJ, Becker RC, Chew DP, French WJ, Leisch F, Parikh KH, Skerjanec S, Bhatt DL. Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med. 2009 Dec 10;361(24):2318-29. doi: 10.1056/NEJMoa0908628.
  • Berger JS, Bhatt DL, Cannon CP, Chen Z, Jiang L, Jones JB, Mehta SR, Sabatine MS, Steinhubl SR, Topol EJ, Berger PB. The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis. J Am Coll Cardiol. 2009 Nov 17;54(21):1935-45. doi: 10.1016/j.jacc.2009.05.074.
  • Cannon CP, Waheed S. Evaluating medical, percutaneous coronary intervention, and coronary artery bypass surgery options for chronic angina: an update of the revised guidelines. Rev Cardiovasc Med. 2009;10 Suppl 1:S21-9.
  • Cannon CP. Introduction: Update on the evaluation and treatment of chronic angina. Rev Cardiovasc Med. 2009;10 Suppl 1:S1-2.
  • Amin AP, Cohen DJ. Cost-effectiveness of alternative approaches to the management of chronic obstructive coronary artery disease. Rev Cardiovasc Med. 2009;10 Suppl 2:S3-13.
  • Anolik R, Elmariah S, Lehrhoff S, Votava HJ, Martiniuk FT, Levis W. Hyperimmunoglobulin E syndrome with a novel STAT3 mutation. Dermatol Online J. 2009 Aug 15;15(8):16.
  • Franco OH, Massaro JM, Civil J, Cobain MR, O’Malley B, D’Agostino RB Sr. Trajectories of entering the metabolic syndrome: the framingham heart study. Circulation. 2009 Nov 17;120(20):1943-50. doi: 10.1161/CIRCULATIONAHA.109.855817. Epub 2009 Nov 2.
  • Kumar A, Cannon CP. Acute coronary syndromes: Diagnosis and management, part II. Mayo Clin Proc. 2009 Nov;84(11):1021-36. doi: 10.1016/S0025-6196(11)60674-5.
  • Meredith IT, Ormiston J, Whitbourn R, Kay IP, Muller D, Cutlip DE; ENDEAVOR I Investigators. Five-year clinical follow-up after implantation of the Endeavor zotarolimus-eluting stent: ENDEAVOR I, first-in-human study. Catheter Cardiovasc Interv. 2009 Dec 1;74(7):989-95. doi: 10.1002/ccd.22206.
  • Meredith IT, Worthley S, Whitbourn R, Walters DL, McClean D, Horrigan M, Popma JJ, Cutlip DE, DePaoli A, Negoita M, Fitzgerald PJ; RESOLUTE Investigators. Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial. JACC Cardiovasc Interv. 2009 Oct;2(10):977-85. doi: 10.1016/j.jcin.2009.07.007.
  • Kirtane AJ, Patel R, O’Shaughnessy C, Overlie P, McLaurin B, Solomon S, Mauri L, Fitzgerald P, Popma JJ, Kandzari DE, Leon MB. Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv. 2009 Oct;2(10):967-76. doi: 10.1016/j.jcin.2009.08.008.
  • Pride YB, Canto JG, Frederick PD, Gibson CM; NRMI Investigators. Outcomes among patients with non-ST-segment elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery. JACC Cardiovasc Interv. 2009 Oct;2(10):944-52. doi: 10.1016/j.jcin.2009.07.008.
  • Kumar K, Zimetbaum PJ. New and emerging antiarrhythmic drugs for atrial fibrillation: what may become available to the clinician in the near future. Curr Treat Options Cardiovasc Med. 2009 Oct;11(5):373-80. doi: 10.1007/s11936-009-0038-0.
  • Albert NM, Yancy CW, Liang L, Zhao X, Hernandez AF, Peterson ED, Cannon CP, Fonarow GC. Use of aldosterone antagonists in heart failure. JAMA. 2009 Oct 21;302(15):1658-65. doi: 10.1001/jama.2009.1493.
  • Depta JP, Cannon CP, Fonarow GC, Zhao X, Peacock WF, Bhatt DL; Get With The Guidelines Steering Committee and Investigators. Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes. Am J Cardiol. 2009 Nov 1;104(9):1171-8. doi: 10.1016/j.amjcard.2009.06.027.
  • Kandzari DE, Colombo A, Park SJ, Tommaso CL, Ellis SG, Guzman LA, Teirstein PS, Tamburino C, Ormiston J, Stone GW, Dangas GD, Popma JJ, Bass TA; American College of Cardiology Interventional Scientific Council. Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards. J Am Coll Cardiol. 2009 Oct 20;54(17):1576-88. doi: 10.1016/j.jacc.2009.07.021.
  • Kelley WE, Januzzi JL, Christenson RH. Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem. 2009 Dec;55(12):2098-112. doi: 10.1373/clinchem.2009.130799. Epub 2009 Oct 8.
  • Steinhart B, Thorpe KE, Bayoumi AM, Moe G, Januzzi JL Jr, Mazer CD. Improving the diagnosis of acute heart failure using a validated prediction model. J Am Coll Cardiol. 2009 Oct 13;54(16):1515-21. doi: 10.1016/j.jacc.2009.05.065.
  • Reynolds MR, Zimetbaum P, Josephson ME, Ellis E, Danilov T, Cohen DJ. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2009 Aug;2(4):362-9. doi: 10.1161/CIRCEP.108.837294. Epub 2009 Apr 17.
  • Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009 Aug;2(4):349-61. doi: 10.1161/CIRCEP.108.824789. Epub 2009 Jun 2.
  • Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ Heart Fail. 2009 Jul;2(4):311-9. doi: 10.1161/CIRCHEARTFAILURE.108.833707. Epub 2009 May 14.
  • Yang X, Popma JJ. “Bailing out” side branches: technique trumps technology, round 1. J Invasive Cardiol. 2009 Oct;21(10):538.
  • Bian Y, Sun M, Silver M, Ho KK, Marchionni MA, Caggiano AO, Stone JR, Amende I, Hampton TG, Morgan JP, Yan X. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins. Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H1974-83. doi: 10.1152/ajpheart.01010.2008. Epub 2009 Oct 2.
  • Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc. 2009 Oct;84(10):917-38. doi: 10.1016/S0025-6196(11)60509-0.
  • Cannon CP, Kumar A. Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options. Clin Cornerstone. 2009;9(4):55-68; discussion 69-71. doi: 10.1016/s1098-3597(09)80005-7.
  • Silber S, Colombo A, Banning AP, Hauptmann K, Drzewiecki J, Grube E, Dudek D, Baim DS. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions. Circulation. 2009 Oct 13;120(15):1498-504. doi: 10.1161/CIRCULATIONAHA.109.849877. Epub 2009 Sep 28.
  • Woo K, Doros G, Ng T, Farber A. Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts. J Vasc Surg. 2009 Dec;50(6):1405-11.e1-2. doi: 10.1016/j.jvs.2009.07.090. Epub 2009 Sep 26.
  • Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O’Hara C, Seldin DC, Skinner M. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am Heart J. 2009 Oct;158(4):607-14. doi: 10.1016/j.ahj.2009.08.006.
  • Nikolsky E, Lansky AJ, Sudhir K, Doostzadeh J, Cutlip DE, Piana R, Su X, White R, Simonton CA, Stone GW. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease. Am Heart J. 2009 Oct;158(4):520-526.e2. doi: 10.1016/j.ahj.2009.07.025. Epub 2009 Aug 26.
  • Cannon CP, Dansky HM, Davidson M, Gotto AM Jr, Brinton EA, Gould AL, Stepanavage M, Liu SX, Shah S, Rubino J, Gibbons P, Hermanowski-Vosatka A, Binkowitz B, Mitchel Y, Barter P; DEFINE investigators. Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib. Am Heart J. 2009 Oct;158(4):513-519.e3. doi: 10.1016/j.ahj.2009.07.028.
  • George JC, Popma JJ. Reduced reimbursement for cardiovascular services by the Centers for Medicare and Medicaid Services: perspective from interventional cardiology. JACC Cardiovasc Interv. 2009 Sep;2(9):894-6. doi: 10.1016/j.jcin.2009.08.002.
  • D’Agostino RB Sr. The delayed-start study design. N Engl J Med. 2009 Sep 24;361(13):1304-6. doi: 10.1056/NEJMsm0904209.
  • Hoekstra JW, O’Neill BJ, Pride YB, Lefebvre C, Diercks DB, Peacock WF, Fermann GJ, Gibson CM, Pinto D, Giglio J, Chandra A, Cairns CB, Konstam MA, Massaro J, Krucoff M. Acute detection of ST-elevation myocardial infarction missed on standard 12-Lead ECG with a novel 80-lead real-time digital body surface map: primary results from the multicenter OCCULT MI trial. Ann Emerg Med. 2009 Dec;54(6):779-788.e1. doi: 10.1016/j.annemergmed.2009.06.525. Epub 2009 Sep 19.
  • Friedewald VE, Gibbons RJ, O’Neill WW, Popma JJ, Stone GW, Roberts WC. The editor’s roundtable: intracoronary hyperoxemic therapy in acute myocardial infarction. Am J Cardiol. 2009 Sep 15;104(6):791-7. doi: 10.1016/j.amjcard.2009.06.018.
  • Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP; REACH Investigators. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry. Crit Pathw Cardiol. 2009 Sep;8(3):104-11. doi: 10.1097/HPC.0b013e3181b8395d.
  • Smith EE, Liang L, Hernandez A, Reeves MJ, Cannon CP, Fonarow GC, Schwamm LH. Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke Program. Neurology. 2009 Sep 1;73(9):709-16. doi: 10.1212/WNL.0b013e3181b59a6e.
  • van Bommel RJ, Bax JJ, Abraham WT, Chung ES, Pires LA, Tavazzi L, Zimetbaum PJ, Gerritse B, Kristiansen N, Ghio S. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J. 2009 Oct;30(20):2470-7. doi: 10.1093/eurheartj/ehp368. Epub 2009 Aug 30.
  • Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009 Sep 10;361(11):1045-57. doi: 10.1056/NEJMoa0904327. Epub 2009 Aug 30.
  • Abrahão AC, Camisasca DR, Bonelli BR, Cabral MG, Lourenço SQ, Torres SR, Pinto DS Jr. Recurrent bilateral gingival peripheral calcifying epithelial odontogenic tumor (Pindborg tumor): a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Sep;108(3):e66-71. doi: 10.1016/j.tripleo.2009.04.037.
  • Ellis ER, Culler SD, Simon AW, Reynolds MR. Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries. Heart Rhythm. 2009 Sep;6(9):1267-73. doi: 10.1016/j.hrthm.2009.06.009. Epub 2009 Jun 6.
  • Cockram CA, Doros G, de Figueiredo JM. Diagnosis and measurement of subjective incompetence: the clinical hallmark of demoralization. Psychother Psychosom. 2009;78(6):342-5. doi: 10.1159/000235737. Epub 2009 Aug 27.
  • Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol. 2009 Sep 1;54(10):894-902. doi: 10.1016/j.jacc.2009.04.077.
  • Mohammed AA, Agnihotri AK, van Kimmenade RR, Martinez-Rumayor A, Green SM, Quiroz R, Januzzi JL Jr. Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery. Circulation. 2009 Sep 8;120(10):843-50. doi: 10.1161/CIRCULATIONAHA.108.837278. Epub 2009 Aug 24.
  • Cannon CP. Should we manage patients with non-ST segment elevation myocardial infarction with renal failure with an invasive strategy?. Circulation. 2009 Sep 8;120(10):828-30. doi: 10.1161/CIRCULATIONAHA.109.888602. Epub 2009 Aug 24.
  • De Luca G, Gibson CM, Huber K, Zeymer U, Dudek D, Cutlip D, Bellandi F, Noc M, Emre A, Zorman S, Gabriel HM, Maioli M, Rakowski T, Gyöngyösi M, Van’t Hof AW; EGYPT Cooperation. Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors. Am Heart J. 2009 Sep;158(3):416-21. doi: 10.1016/j.ahj.2009.06.029.
  • Pride YB, Wiviott SD, Buros JL, Zorkun C, Tariq MU, Antman EM, Braunwald E, Gibson CM; TIMI Study Group. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy. Am Heart J. 2009 Sep;158(3):e21-6. doi: 10.1016/j.ahj.2009.06.021.
  • Swahn MH, Reynolds MR, Tice M, Miranda-Pierangeli MC, Jones CR, Jones IR. Perceived overweight, BMI, and risk for suicide attempts: findings from the 2007 Youth Risk Behavior Survey. J Adolesc Health. 2009 Sep;45(3):292-5. doi: 10.1016/j.jadohealth.2009.03.006. Epub 2009 May 18.
  • Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I. Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol. 2009 Sep 1;104(5):671-7. doi: 10.1016/j.amjcard.2009.04.040.
  • Dieplinger B, Januzzi JL Jr, Steinmair M, Gabriel C, Poelz W, Haltmayer M, Mueller T. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma–the Presage ST2 assay. Clin Chim Acta. 2009 Nov;409(1-2):33-40. doi: 10.1016/j.cca.2009.08.010. Epub 2009 Aug 20.
  • Novack V, Cutlip D, Kleiman N, Pencina M, Mauri L, Yen CH, Berger P, Goldberg S, Kellett M, Waksman R, Hong M, Raizner AE, Cohen DJ. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Aug;2(8):767-75. doi: 10.1016/j.jcin.2009.05.016.
  • Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL. Association between anxiety and C-reactive protein levels in stable coronary heart disease patients. Psychosomatics. 2009 Jul-Aug;50(4):347-53. doi: 10.1176/appi.psy.50.4.347.
  • Campos MS, Garcia-Rejas RA, Pinto DS Jr, de Sousa SC, Nunes FD. Intravascular papillary endothelial hyperplasia: report of 4 cases with immunohistochemical findings. Med Oral Patol Oral Cir Bucal. 2009 Oct 1;14(10):e506-9. doi: 10.4317/medoral.14.e506.
  • Wang TY, Fonarow GC, Hernandez AF, Liang L, Ellrodt G, Nallamothu BK, Shah BR, Cannon CP, Peterson ED. The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomes. Arch Intern Med. 2009 Aug 10;169(15):1411-9. doi: 10.1001/archinternmed.2009.223.
  • Mega JL, Morrow DA, Brown A, Cannon CP, Sabatine MS. Identification of genetic variants associated with response to statin therapy. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1310-5. doi: 10.1161/ATVBAHA.109.188474. Epub 2009 Aug 10.
  • Murphy TP, Hirsch AT, Cutlip DE, Regensteiner JG, Comerota AJ, Mohler E, Cohen DJ, Massaro J; CLEVER Investigators. Claudication: exercise vs endoluminal revascularization (CLEVER) study update. J Vasc Surg. 2009 Oct;50(4):942-945.e2. doi: 10.1016/j.jvs.2009.04.076. Epub 2009 Aug 5.
  • Pride YB, Appelbaum E, Lord EE, Sloan S, Cannon CP, Sabatine MS, Gibson CM; TIMI Study Group. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction. Am J Cardiol. 2009 Aug 15;104(4):475-9. doi: 10.1016/j.amjcard.2009.04.005. Epub 2009 Jun 17.
  • Ghosh S, Dutta S, Gomes E, Carroll D, D’Agostino R Jr, Olson J, Guthold M, Gmeiner WH. Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano. 2009 Sep 22;3(9):2667-73. doi: 10.1021/nn900368b.
  • Brilakis ES, Hernandez AF, Dai D, Peterson ED, Banerjee S, Fonarow GC, Cannon CP, Bhatt DL. Quality of care for acute coronary syndrome patients with known atherosclerotic disease: results from the Get With the Guidelines Program. Circulation. 2009 Aug 18;120(7):560-7. doi: 10.1161/CIRCULATIONAHA.109.877092. Epub 2009 Aug 3.
  • Berz JP, Johnston K, Backus B, Doros G, Rose AJ, Pierre S, Battaglia TA. The influence of black race on treatment and mortality for early-stage breast cancer. Med Care. 2009 Sep;47(9):986-92. doi: 10.1097/MLR.0b013e31819e1f2b.
  • Brown TM, Hernandez AF, Bittner V, Cannon CP, Ellrodt G, Liang L, Peterson ED, Piña IL, Safford MM, Fonarow GC; American Heart Association Get With The Guidelines Investigators. Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association’s Get With The Guidelines Program. J Am Coll Cardiol. 2009 Aug 4;54(6):515-21. doi: 10.1016/j.jacc.2009.02.080.
  • Storey RF, Melissa Thornton S, Lawrance R, Husted S, Wickens M, Emanuelsson H, Cannon CP, Heptinstall S, Armstrong M. Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3. Platelets. 2009 Aug;20(5):341-8. doi: 10.1080/09537100903075324.
  • Mohammed AA, Januzzi JL Jr. Natriuretic peptides in the diagnosis and management of acute heart failure. Heart Fail Clin. 2009 Oct;5(4):489-500. doi: 10.1016/j.hfc.2009.04.007.
  • Frutkin AD, Lindsey JB, Mehta SK, House JA, Spertus JA, Cohen DJ, Rumsfeld JS, Marso SP; NCDR (National Cardiovascular Data Registry). Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2009 Jul;2(7):614-21. doi: 10.1016/j.jcin.2009.05.001.
  • van der Zee S, Baber U, Elmariah S, Winston J, Fuster V. Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol. 2009 Sep;6(9):580-9. doi: 10.1038/nrcardio.2009.121. Epub 2009 Jul 21.
  • Burke A, Ding X, Singh R, Kraft RA, Levi-Polyachenko N, Rylander MN, Szot C, Buchanan C, Whitney J, Fisher J, Hatcher HC, D’Agostino R Jr, Kock ND, Ajayan PM, Carroll DL, Akman S, Torti FM, Torti SV. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12897-902. doi: 10.1073/pnas.0905195106. Epub 2009 Jul 20.
  • Januzzi JL, Bayes-Genis A. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure. Drug News Perspect. 2009 Jun;22(5):267-73. doi: 10.1358/dnp.2009.22.5.1378643.
  • Lopes RD, Hafley GE, Allen KB, Ferguson TB, Peterson ED, Harrington RA, Mehta RH, Gibson CM, Mack MJ, Kouchoukos NT, Califf RM, Alexander JH. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med. 2009 Jul 16;361(3):235-44. doi: 10.1056/NEJMoa0900708.
  • Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV, Schnabel RB, Bis JC, Boerwinkle E, Sinner MF, Dehghan A, Lubitz SA, D’Agostino RB Sr, Lumley T, Ehret GB, Heeringa J, Aspelund T, Newton-Cheh C, Larson MG, Marciante KD, Soliman EZ, Rivadeneira F, Wang TJ, Eiríksdottir G, Levy D, Psaty BM, Li M, Chamberlain AM, Hofman A, Vasan RS, Harris TB, Rotter JI, Kao WH, Agarwal SK, Stricker BH, Wang K, Launer LJ, Smith NL, Chakravarti A, Uitterlinden AG, Wolf PA, Sotoodehnia N, Köttgen A, van Duijn CM, Meitinger T, Mueller M, Perz S, Steinbeck G, Wichmann HE, Lunetta KL, Heckbert SR, Gudnason V, Alonso A, Kääb S, Ellinor PT, Witteman JC. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet. 2009 Aug;41(8):879-81. doi: 10.1038/ng.416. Epub 2009 Jul 13.
  • Laine L, Connors L, Griffin MR, Curtis SP, Kaur A, Cannon CP. Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines. Aliment Pharmacol Ther. 2009 Oct;30(7):767-74. doi: 10.1111/j.1365-2036.2009.04090.x. Epub 2009 Jul 7.
  • Smith AJ, Karpova Y, D’Agostino R Jr, Willingham M, Kulik G. Expression of the Bcl-2 protein BAD promotes prostate cancer growth. PLoS One. 2009 Jul 13;4(7):e6224. doi: 10.1371/journal.pone.0006224.
  • Truong QA, Okada DR, Cannon CP. Cardiac risk – coronary calcium scoring for all?. Rev Cardiovasc Med. 2009 Spring;10(2):121-4.
  • Sam S, Haffner S, Davidson MH, D’Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care. 2009 Oct;32(10):1916-20. doi: 10.2337/dc09-0412. Epub 2009 Jul 10.
  • Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009 Jul 14;54(3):220-8. doi: 10.1016/j.jacc.2009.05.006.
  • Preis SR, Pencina MJ, Hwang SJ, D’Agostino RB Sr, Savage PJ, Levy D, Fox CS. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation. 2009 Jul 21;120(3):212-20. doi: 10.1161/CIRCULATIONAHA.108.846519. Epub 2009 Jul 6.
  • Lasala JM, Cox DA, Lewis SJ, Tadros PN, Haas RC, Schweiger MJ, Chhabra A, Untereker WJ, Starzyk RM, Mascioli SR, Dawkins KD, Baim DS. Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programme. EuroIntervention. 2009 May;5(1):67-77. doi: 10.4244/eijv5i1a11.
  • Piazza N, Cutlip DE, Onuma Y, Kappetein AP, de Jaegere P, Serruys PW. Clinical endpoints in transcatheter aortic valve implantation: a call to ARC for standardised definitions. EuroIntervention. 2009 May;5(1):29-31. doi: 10.4244/eijv5i1a5.
  • Jensen JK, Atar D, Kristensen SR, Mickley H, Januzzi JL Jr. Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke. Am J Cardiol. 2009 Jul 15;104(2):287-91. doi: 10.1016/j.amjcard.2009.03.029. Epub 2009 May 13.
  • Baggish AL, Weiner RB, Yared K, Wang F, Kupperman E, Hutter AM Jr, Picard MH, Wood MJ. Impact of family hypertension history on exercise-induced cardiac remodeling. Am J Cardiol. 2009 Jul 1;104(1):101-6. doi: 10.1016/j.amjcard.2009.02.052.
  • Gibson CM, Pride YB, Buros JL, Ciaglo LN, Morrow DA, Scirica BM, Stone PH; TIMI Study Group. Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis). Am J Cardiol. 2009 Jul 1;104(1):36-40. doi: 10.1016/j.amjcard.2009.02.044. Epub 2009 May 4.
  • Gilbert NF, Yasko AW, Oates SD, Lewis VO, Cannon CP, Lin PP. Allograft-prosthetic composite reconstruction of the proximal part of the tibia. An analysis of the early results. J Bone Joint Surg Am. 2009 Jul;91(7):1646-56. doi: 10.2106/JBJS.G.01542.
  • Wilson GJ, Nakazawa G, Schwartz RS, Huibregtse B, Poff B, Herbst TJ, Baim DS, Virmani R. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation. 2009 Jul 14;120(2):141-9, 1-2. doi: 10.1161/CIRCULATIONAHA.107.730010. Epub 2009 Jun 29.
  • Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009 Jul;32(7):1153-7. doi: 10.2337/dc08-2127.
  • Neilan TG, Wood MJ. Endurance exercise and the heart: multiple benefits but many unanswered questions. J Am Soc Echocardiogr. 2009 Jul;22(7):810-3. doi: 10.1016/j.echo.2009.05.008.
  • Maahs DM, Hamman RF, D’Agostino R Jr, Dolan LM, Imperatore G, Lawrence JM, Marcovina SM, Mayer-Davis EJ, Pihoker C, Dabelea D. The association between adiponectin/leptin ratio and diabetes type: the SEARCH for Diabetes in Youth Study. J Pediatr. 2009 Jul;155(1):133-5, 135.e1. doi: 10.1016/j.jpeds.2008.12.048.
  • Appelbaum E, Abraham JM, Pride YB, Harrigan CJ, Peters DC, Biller LH, Manning WJ, Gibson CM. Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am Heart J. 2009 Jul;158(1):84-91. doi: 10.1016/j.ahj.2009.04.012.
  • Mega JL, Braunwald E, Mohanavelu S, Burton P, Poulter R, Misselwitz F, Hricak V, Barnathan ES, Bordes P, Witkowski A, Markov V, Oppenheimer L, Gibson CM; ATLAS ACS-TIMI 46 study group. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet. 2009 Jul 4;374(9683):29-38. doi: 10.1016/S0140-6736(09)60738-8. Epub 2009 Jun 17.
  • Leon MB, Allocco DJ, Dawkins KD, Baim DS. Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events. JACC Cardiovasc Interv. 2009 Jun;2(6):504-12. doi: 10.1016/j.jcin.2009.04.004.
  • Chacko R, Mulhearn M, Novack V, Novack L, Mauri L, Cohen SA, Moses J, Leon MB, Cutlip DE. Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting. JACC Cardiovasc Interv. 2009 Jun;2(6):498-503. doi: 10.1016/j.jcin.2009.03.013.
  • Gupta GR, Yasko AW, Lewis VO, Cannon CP, Raymond AK, Patel S, Lin PP. Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus. Cancer. 2009 Aug 15;115(16):3767-73. doi: 10.1002/cncr.24443.
  • Krum H, Swergold G, Curtis SP, Kaur A, Wang H, Smugar SS, Weir MR, Laine L, Brater DC, Cannon CP. Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study. J Hypertens. 2009 Apr;27(4):886-93. doi: 10.1097/HJH.0b013e328325d831.
  • Pencina MJ, D’Agostino RB Sr, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation. 2009 Jun 23;119(24):3078-84. doi: 10.1161/CIRCULATIONAHA.108.816694. Epub 2009 Jun 8.
  • Hollander JE, Gibson CM, Pollack CV Jr. Hospitals with and without percutaneous coronary intervention capability: considerations for treating acute coronary syndromes. Am J Emerg Med. 2009 Jun;27(5):595-606. doi: 10.1016/j.ajem.2008.04.019.
  • Shah RV, Chen-Tournoux AA, Picard MH, Januzzi JL. Association between troponin T and impaired left ventricular relaxation in patients with acute decompensated heart failure with preserved systolic function. Eur J Echocardiogr. 2009 Aug;10(6):765-8. doi: 10.1093/ejechocard/jep063. Epub 2009 May 30.
  • Petrich W, Lewandrowski KB, Muhlestein JB, Hammond ME, Januzzi JL, Lewandrowski EL, Pearson RR, Dolenko B, Früh J, Haass M, Hirschl MM, Köhler W, Mischler R, Möcks J, Ordóñez-Llanos J, Quarder O, Somorjai R, Staib A, Sylvén C, Werner G, Zerback R. Potential of mid-infrared spectroscopy to aid the triage of patients with acute chest pain. Analyst. 2009 Jun;134(6):1092-8. doi: 10.1039/b820923e. Epub 2009 Apr 15.
  • Korngold EC, Januzzi JL Jr, Gantzer ML, Moorthy MV, Cook NR, Albert CM. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women. Circulation. 2009 Jun 9;119(22):2868-76. doi: 10.1161/CIRCULATIONAHA.108.832576. Epub 2009 May 26.
  • Frisch DR, Haim M, Zimetbaum PJ, Josephson ME. Multiblock’: what is the mechanism?. Heart Rhythm. 2009 Jun;6(6):860-2. doi: 10.1016/j.hrthm.2008.07.018. Epub 2008 Jul 24.
  • Forman DE, Cannon CP, Hernandez AF, Liang L, Yancy C, Fonarow GC; Get With the Guidelines Steering Committee and Hospitals. Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF). Am Heart J. 2009 Jun;157(6):1010-7. doi: 10.1016/j.ahj.2009.03.010. Epub 2009 Apr 25.
  • Dangas GD, Popma JJ; ACC Interventional Scientific Council. JACC White Papers: an avenue for interventional knowledge?. JACC Cardiovasc Interv. 2009 May;2(5):472-3. doi: 10.1016/j.jcin.2009.03.008.
  • Mahmud E, Ormiston JA, Turco MA, Popma JJ, Weissman NJ, O’Shaughnessy CD, Mann T, Hall JJ, McGarry TF, Cannon LA, Webster MW, Mandinov L, Baim DS. TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program. JACC Cardiovasc Interv. 2009 Mar;2(3):240-52. doi: 10.1016/j.jcin.2008.12.009.
  • Latif F, Kleiman NS, Cohen DJ, Pencina MJ, Yen CH, Cutlip DE, Moliterno DJ, Nassif D, Lopez JJ, Saucedo JF; EVENT Investigators. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Jan;2(1):37-45. doi: 10.1016/j.jcin.2008.06.012.
  • Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, Sanchorawala V. Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease. Haematologica. 2009 Jul;94(7):1029-32. doi: 10.3324/haematol.2008.001925. Epub 2009 May 19.
  • Bainey KR, Fu Y, Granger CB, Hamm CW, Holmes DR Jr, O’Neill WW, Seabra-Gomes R, Pfisterer ME, Van de Werf F, Armstrong PW; APEX AMI Investigators. Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?. Heart. 2009 Aug;95(16):1331-6. doi: 10.1136/hrt.2008.160390. Epub 2009 May 15.
  • Fredman L, Doros G, Ensrud KE, Hochberg MC, Cauley JA. Caregiving intensity and change in physical functioning over a 2-year period: results of the caregiver-study of osteoporotic fractures. Am J Epidemiol. 2009 Jul 15;170(2):203-10. doi: 10.1093/aje/kwp102. Epub 2009 May 14.
  • Mohammed AA, Januzzi JL Jr. Natriuretic peptide guided heart failure management. Curr Clin Pharmacol. 2009 May;4(2):87-94. doi: 10.2174/157488409788184945.
  • Matthan NR, Pencina M, LaRocque JM, Jacques PF, D’Agostino RB, Schaefer EJ, Lichtenstein AH. Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. J Lipid Res. 2009 Sep;50(9):1927-35. doi: 10.1194/jlr.P900039-JLR200. Epub 2009 May 12.
  • De Luca G, Gibson CM, Bellandi F, Noc M, Dudek D, Zeymer U, Arntz HR, Cutlip D, Maioli M, Zorman S, Mesquita Gabriel H, Emre A, Rakowski T, Gyongyosi M, Huber K, Van’t Hof AW. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors. Atherosclerosis. 2009 Nov;207(1):181-5. doi: 10.1016/j.atherosclerosis.2009.03.042. Epub 2009 Apr 5.
  • Chambers CE, Dehmer GJ, Cox DA, Harrington RA, Babb JD, Popma JJ, Turco MA, Weiner BH, Tommaso CL; Society for Cardiovascular Angiography and Interventions. Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation. Catheter Cardiovasc Interv. 2009 Jun 1;73(7):847-58. doi: 10.1002/ccd.22100.
  • Charytan DM, Wallentin L, Lagerqvist B, Spacek R, De Winter RJ, Stern NM, Braunwald E, Cannon CP, Choudhry NK. Early angiography in patients with chronic kidney disease: a collaborative systematic review. Clin J Am Soc Nephrol. 2009 Jun;4(6):1032-43. doi: 10.2215/CJN.05551008. Epub 2009 May 7.
  • Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Steg PG, Cannon CP, Brennan DM, Bhatt DL; REACH Registry Investigators. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry. Crit Pathw Cardiol. 2009 Jun;8(2):91-7. doi: 10.1097/HPC.0b013e3181a84613.
  • Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009 May 19;119(19):2545-52. doi: 10.1161/CIRCULATIONAHA.108.844506. Epub 2009 May 4.
  • Darge A, Reynolds MR, Germano JJ. Advances in atrial fibrillation ablation. J Invasive Cardiol. 2009 May;21(5):247-54.
  • Bajwa EK, Khan UA, Januzzi JL, Gong MN, Thompson BT, Christiani DC. Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest. 2009 Aug;136(2):471-480. doi: 10.1378/chest.08-2413. Epub 2009 May 1.
  • Frisch DR, Giedrimas E, Mohanavelu S, Shui A, Ho KK, Gibson CM, Josephson ME, Zimetbaum PJ. Predicting irreversible left ventricular dysfunction after acute myocardial infarction. Am J Cardiol. 2009 May 1;103(9):1206-9. doi: 10.1016/j.amjcard.2009.01.028.
  • Zimetbaum PJ. Dronedarone for atrial fibrillation–an odyssey. N Engl J Med. 2009 Apr 30;360(18):1811-3. doi: 10.1056/NEJMp0902248.
  • Wilson NA, Keele BF, Reed JS, Piaskowski SM, MacNair CE, Bett AJ, Liang X, Wang F, Thoryk E, Heidecker GJ, Citron MP, Huang L, Lin J, Vitelli S, Ahn CD, Kaizu M, Maness NJ, Reynolds MR, Friedrich TC, Loffredo JT, Rakasz EG, Erickson S, Allison DB, Piatak M Jr, Lifson JD, Shiver JW, Casimiro DR, Shaw GM, Hahn BH, Watkins DI. Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. J Virol. 2009 Jul;83(13):6508-21. doi: 10.1128/JVI.00272-09. Epub 2009 Apr 29.
  • Schnipper JL, Hamann C, Ndumele CD, Liang CL, Carty MG, Karson AS, Bhan I, Coley CM, Poon E, Turchin A, Labonville SA, Diedrichsen EK, Lipsitz S, Broverman CA, McCarthy P, Gandhi TK. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial. Arch Intern Med. 2009 Apr 27;169(8):771-80. doi: 10.1001/archinternmed.2009.51.
  • Peacock WF, Fonarow GC, Ander DS, Collins SP, Gheorghiade M, Kirk JD, Filippatos G, Diercks DB, Trupp RJ, Hiestand B, Amsterdam EA, Abraham WT, Amsterdam EA, Dodge G, Gaieski DF, Gurney D, Hayes CO, Hollander JE, Holmes K, Januzzi JL Jr, Levy P, Maisel A, Miller CD, Pang PS, Selby E, Storrow AB, Weintraub NL, Yancy CW, Bahr RD, Blomkalns AL, McCord J, Nowak RM, Stomel RJ. Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6. Acute Card Care. 2009;11(1):3-42. doi: 10.1080/02652040802688690.
  • Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Popma JJ, Teirstein PS, Cohen SA, Wang H, Cutlip DE, Moses JW. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. J Am Coll Cardiol. 2009 Apr 28;53(17):1488-97. doi: 10.1016/j.jacc.2009.01.050.
  • Krum H, Curtis SP, Kaur A, Wang H, Smugar SS, Weir MR, Laine L, Brater DC, Cannon CP. Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program. Eur J Heart Fail. 2009 Jun;11(6):542-50. doi: 10.1093/eurjhf/hfp054. Epub 2009 Apr 19.
  • Price MJ, Berger PB, Angiolillo DJ, Teirstein PS, Tanguay JF, Kandzari DE, Cannon CP, Topol EJ. Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial. Am Heart J. 2009 May;157(5):818-24, 824.e1. doi: 10.1016/j.ahj.2009.02.012.
  • Truong QA, Cannon CP. Cardiac resynchronization therapy. A perspective on PROSPECT and the continued search for predictors to CRT response. Rev Cardiovasc Med. 2009 Winter;10(1):59-61.
  • Tung P, Wiviott SD, Cannon CP, Murphy SA, McCabe CH, Gibson CM. Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study). Am J Cardiol. 2009 Apr 15;103(8):1056-60. doi: 10.1016/j.amjcard.2008.12.034. Epub 2009 Feb 21.
  • Nallamothu BK, Krumholz HM, Peterson ED, Pan W, Bradley E, Stern AF, Masoudi FA, Janicke DM, Hernandez AF, Cannon CP, Fonarow GC; D2B Alliance and the American Heart Association Get-With-The-Guidelines Investigators. Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) Alliance. Am J Cardiol. 2009 Apr 15;103(8):1051-5. doi: 10.1016/j.amjcard.2008.12.030. Epub 2009 Feb 28.
  • Desai NR, Mega JL, Jiang S, Cannon CP, Sabatine MS. Interaction between cigarette smoking and clinical benefit of clopidogrel. J Am Coll Cardiol. 2009 Apr 14;53(15):1273-8. doi: 10.1016/j.jacc.2008.12.044.
  • Joseph J, Pencina MJ, Wang TJ, Hayes L, Tofler GH, Jacques P, Selhub J, Levy D, D’Agostino RB Sr, Benjamin EJ, Vasan RS. Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community. J Hypertens. 2009 Jun;27(6):1317-24. doi: 10.1097/HJH.0b013e328329fc20.
  • Yared K, Baggish AL, Wood MJ. High-output heart failure resulting from a remote traumatic arteriovenous fistula. Can J Cardiol. 2009 Apr;25(4):e143-4. doi: 10.1016/s0828-282x(09)70083-2.
  • Bhatt DL, Peterson ED, Harrington RA, Ou FS, Cannon CP, Gibson CM, Kleiman NS, Brindis RG, Peacock WF, Brener SJ, Menon V, Smith SC Jr, Pollack CV Jr, Gibler WB, Ohman EM, Roe MT; CRUSADE Investigators. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J. 2009 May;30(10):1195-202. doi: 10.1093/eurheartj/ehp099. Epub 2009 Apr 1.
  • Cannon CP. Can the polypill save the world from heart disease?. Lancet. 2009 Apr 18;373(9672):1313-4. doi: 10.1016/S0140-6736(09)60652-8. Epub 2009 Mar 30.
  • Husted S, Harrington RA, Cannon CP, Storey RF, Mitchell P, Emanuelsson H. Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial. Int J Clin Pract. 2009 Apr;63(4):667-70. doi: 10.1111/j.1742-1241.2009.02030.x.
  • Yared K, Wood MJ. Is marathon running hazardous to your cardiovascular health? The jury is still out. Radiology. 2009 Apr;251(1):3-5. doi: 10.1148/radiol.2511090041.
  • Wang TY, Zhang M, Fu Y, Armstrong PW, Newby LK, Gibson CM, Moliterno DJ, Van de Werf F, White HD, Harrington RA, Roe MT. Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography. Am Heart J. 2009 Apr;157(4):716-23. doi: 10.1016/j.ahj.2009.01.004.
  • Truong QA, Cannon CP, Zakai NA, Rogers IS, Giugliano RP, Wiviott SD, McCabe CH, Morrow DA, Braunwald E. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial. Am Heart J. 2009 Apr;157(4):673-9.e1. doi: 10.1016/j.ahj.2008.12.010. Epub 2009 Feb 23.
  • James S, Akerblom A, Cannon CP, Emanuelsson H, Husted S, Katus H, Skene A, Steg PG, Storey RF, Harrington R, Becker R, Wallentin L. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J. 2009 Apr;157(4):599-605. doi: 10.1016/j.ahj.2009.01.003.
  • Gilon D, Mehta RH, Oh JK, Januzzi JL Jr, Bossone E, Cooper JV, Smith DE, Fang J, Nienaber CA, Eagle KA, Isselbacher EM; International Registry of Acute Aortic Dissection Group. Characteristics and in-hospital outcomes of patients with cardiac tamponade complicating type A acute aortic dissection. Am J Cardiol. 2009 Apr 1;103(7):1029-31. doi: 10.1016/j.amjcard.2008.12.013.
  • Mayor M, Malik AZ, Minor RJ Jr, Deshpande MC, Strauss WE, Maloney TH, Baim DS, O’Neill W, Kandzari DE. One-year outcomes from the TAXUS express stent versus cypher stent. Am J Cardiol. 2009 Apr 1;103(7):930-6. doi: 10.1016/j.amjcard.2008.11.052. Epub 2009 Feb 7.
  • Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol. 2009 Apr 1;103(7):923-9. doi: 10.1016/j.amjcard.2008.12.022.
  • Preis SR, Hwang SJ, Coady S, Pencina MJ, D’Agostino RB Sr, Savage PJ, Levy D, Fox CS. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation. 2009 Apr 7;119(13):1728-35. doi: 10.1161/CIRCULATIONAHA.108.829176. Epub 2009 Mar 23.
  • Green SM, Green JA, Januzzi JL Jr. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting. Am J Ther. 2009 Mar-Apr;16(2):171-7. doi: 10.1097/MJT.0b013e318172797f.
  • Fox CS, Gona P, Hoffmann U, Porter SA, Salton CJ, Massaro JM, Levy D, Larson MG, D’Agostino RB Sr, O’Donnell CJ, Manning WJ. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation. 2009 Mar 31;119(12):1586-91. doi: 10.1161/CIRCULATIONAHA.108.828970. Epub 2009 Mar 16.
  • Gibson CM, Hunter MS. Negative fitness consequences and transmission dynamics of a heritable fungal symbiont of a parasitic wasp. Appl Environ Microbiol. 2009 May;75(10):3115-9. doi: 10.1128/AEM.00361-09. Epub 2009 Mar 13.
  • van Kimmenade RR, Januzzi JL Jr. The evolution of the natriuretic peptides – Current applications in human and animal medicine. J Vet Cardiol. 2009 May;11 Suppl 1:S9-21. doi: 10.1016/j.jvc.2009.01.001. Epub 2009 Mar 14.
  • Howard G, Cushman M, Prineas RJ, Howard VJ, Moy CS, Sullivan LM, D’Agostino RB Sr, McClure LA, Pulley L, Safford MM. Advancing the hypothesis that geographic variations in risk factors contribute relatively little to observed geographic variations in heart disease and stroke mortality. Prev Med. 2009 Aug-Sep;49(2-3):129-32. doi: 10.1016/j.ypmed.2009.03.004. Epub 2009 Mar 11.
  • Aboushwareb T, Zhou G, Deng FM, Turner C, Andersson KE, Tar M, Zhao W, Melman A, D’Agostino R Jr, Sun TT, Christ GJ. Alterations in bladder function associated with urothelial defects in uroplakin II and IIIa knockout mice. Neurourol Urodyn. 2009;28(8):1028-33. doi: 10.1002/nau.20688.
  • van Kimmenade RR, Januzzi JL Jr. Whose heart will get broken? Troponin testing and future heart failure. Eur Heart J. 2009 Apr;30(7):755-6. doi: 10.1093/eurheartj/ehp092. Epub 2009 Mar 4.
  • van Kimmenade RR, Januzzi JL Jr, Bakker JA, Houben AJ, Rennenberg R, Kroon AA, Crijns HJ, van Dieijen-Visser MP, de Leeuw PW, Pinto YM. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol. 2009 Mar 10;53(10):884-90. doi: 10.1016/j.jacc.2008.11.032.
  • Turchin A, Shubina M, Breydo E, Pendergrass ML, Einbinder JS. Comparison of information content of structured and narrative text data sources on the example of medication intensification. J Am Med Inform Assoc. 2009 May-Jun;16(3):362-70. doi: 10.1197/jamia.M2777. Epub 2009 Mar 4.
  • Cannon CP, Hoekstra JW, Larson DM, Mencia WA, Cornish J, Carter RD, Berry CA, Karcher RB. Individual quality improvement in acute coronary syndromes: a performance improvement initiative. Crit Pathw Cardiol. 2009 Mar;8(1):43-8. doi: 10.1097/HPC.0b013e3181980f75.
  • Pollack CV Jr, Hollander JE, Chen AY, Peterson ED, Bangalore S, Peacock FW, Cannon CP, Canto JG, Gibler BW, Ohman ME, Roe MT. Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiative. Crit Pathw Cardiol. 2009 Mar;8(1):29-33. doi: 10.1097/HPC.0b013e3181980f9f.
  • Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D’Agostino RB Sr, Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009 Feb 28;373(9665):739-45. doi: 10.1016/S0140-6736(09)60443-8.
  • Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EM; TRITON-TIMI 38 investigators. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet. 2009 Feb 28;373(9665):723-31. doi: 10.1016/S0140-6736(09)60441-4.
  • Sego LH, Reynolds MR Jr, Woodall WH. Risk-adjusted monitoring of survival times. Stat Med. 2009 Apr 30;28(9):1386-401. doi: 10.1002/sim.3546.
  • Mayer-Davis EJ, Bell RA, Dabelea D, D’Agostino R Jr, Imperatore G, Lawrence JM, Liu L, Marcovina S; SEARCH for Diabetes in Youth Study Group. The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009 Mar;32 Suppl 2(Suppl 2):S99-101. doi: 10.2337/dc09-S201.
  • Mayer-Davis EJ, Beyer J, Bell RA, Dabelea D, D’Agostino R Jr, Imperatore G, Lawrence JM, Liese AD, Liu L, Marcovina S, Rodriguez B; SEARCH for Diabetes in Youth Study Group. Diabetes in African American youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009 Mar;32 Suppl 2(Suppl 2):S112-22. doi: 10.2337/dc09-S203.
  • Frankel DS, Vasan RS, D’Agostino RB Sr, Benjamin EJ, Levy D, Wang TJ, Meigs JB. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol. 2009 Mar 3;53(9):754-62. doi: 10.1016/j.jacc.2008.07.073. Epub 2008 Dec 26.
  • Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL. Association between major depressive disorder and C-reactive protein levels in stable coronary heart disease patients. J Psychosom Res. 2009 Mar;66(3):189-94. doi: 10.1016/j.jpsychores.2008.09.010. Epub 2008 Oct 9.
  • D’Agostino R, Tarantino V, Calevo MG. Post-tonsillectomy late haemorrhage: is it a preferably night-time event?. Int J Pediatr Otorhinolaryngol. 2009 May;73(5):713-6. doi: 10.1016/j.ijporl.2009.01.011. Epub 2009 Feb 23.
  • Sam S, Haffner S, Davidson MH, D’Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care. 2009 May;32(5):932-7. doi: 10.2337/dc08-1856. Epub 2009 Feb 19.
  • Combe B, Swergold G, McLay J, McCarthy T, Zerbini C, Emery P, Connors L, Kaur A, Curtis S, Laine L, Cannon CP. Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study). Rheumatology (Oxford). 2009 Apr;48(4):425-32. doi: 10.1093/rheumatology/kep005. Epub 2009 Feb 17.
  • Fibrinogen Studies Collaboration, Jackson D, White I, Kostis JB, Wilson AC, Folsom AR, Wu K, Chambless L, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Thompson SG, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, D’Agostino R, Kannel WB, Wilson PW, Tofler G, Levy D, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen J, Nyyssönen K, Tuomainen TP, Hedblad B, Engström G, Berglund G, Loewel H, Koenig W, Hense HW, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Iso H, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Despres JP, Dagenais GR, Tunstall-Pedoe H, Lowe GD, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Meade TW, Rudnicka A, Brennan P, Knottenbelt C, Cooper JA, Ridker P, Rodeghiero F, et al. Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med. 2009 Apr 15;28(8):1218-37. doi: 10.1002/sim.3540.
  • Liu E, McKeown NM, Newby PK, Meigs JB, Vasan RS, Quatromoni PA, D’Agostino RB, Jacques PF. Cross-sectional association of dietary patterns with insulin-resistant phenotypes among adults without diabetes in the Framingham Offspring Study. Br J Nutr. 2009 Aug;102(4):576-83. doi: 10.1017/S0007114509220836. Epub 2009 Feb 16.
  • Yeh RW, Baron SJ, Healy JL, Pomerantsev E, McNulty IA, Cruz-Gonzalez I, Jang IK. Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes. Catheter Cardiovasc Interv. 2009 Aug 1;74(2):359-64. doi: 10.1002/ccd.21999.
  • Fuster V, van der Zee S, Elmariah S, Bonow RO. Academic careers in cardiovascular medicine. Circulation. 2009 Feb 10;119(5):754-60. doi: 10.1161/CIRCULATIONAHA.108.792564.
  • Ingelsson E, Massaro JM, Sutherland P, Jacques PF, Levy D, D’Agostino RB, Vasan RS, Robins SJ. Contemporary trends in dyslipidemia in the Framingham Heart Study. Arch Intern Med. 2009 Feb 9;169(3):279-86. doi: 10.1001/archinternmed.2008.561.
  • Dietrich M, Jacques PF, Pencina MJ, Lanier K, Keyes MJ, Kaur G, Wolf PA, D’Agostino RB, Vasan RS. Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role?. Atherosclerosis. 2009 Aug;205(2):549-53. doi: 10.1016/j.atherosclerosis.2008.12.019. Epub 2008 Dec 24.
  • Liu J, Maehara A, Mintz GS, Weissman NJ, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Stone GW. An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. Am J Cardiol. 2009 Feb 15;103(4):501-6. doi: 10.1016/j.amjcard.2008.10.010. Epub 2008 Dec 25.
  • Cannon CP, Paraliticci GU, Lin PP, Lewis VO, Yasko AW. Functional outcome following endoprosthetic reconstruction of the proximal humerus. J Shoulder Elbow Surg. 2009 Sep-Oct;18(5):705-10. doi: 10.1016/j.jse.2008.10.011. Epub 2009 Jan 30.
  • Novack V, Tsyvine D, Cohen DJ, Pencina M, Dubin J, Dehghani H, Kleiman NS, Cutlip DE. Multivessel drug-eluting stenting and impact of diabetes mellitus–a report from the EVENT registry. Catheter Cardiovasc Interv. 2009 Jun 1;73(7):874-80. doi: 10.1002/ccd.21925.
  • Laine L, Goldkind L, Curtis SP, Connors LG, Yanqiong Z, Cannon CP. How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial. Am J Gastroenterol. 2009 Feb;104(2):356-62. doi: 10.1038/ajg.2008.149. Epub 2009 Jan 27.
  • Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL; SPIRIT III Investigators. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation. 2009 Feb 10;119(5):680-6. doi: 10.1161/CIRCULATIONAHA.108.803528. Epub 2009 Jan 26.
  • van der Meer P, Groenveld HF, Januzzi JL Jr, van Veldhuisen DJ. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart. 2009 Aug;95(16):1309-14. doi: 10.1136/hrt.2008.161091. Epub 2009 Jan 23.
  • Christ GJ, Andersson KE, Williams K, Zhao W, D’Agostino R Jr, Kaplan J, Aboushwareb T, Yoo J, Calenda G, Davies KP, Sellers RS, Melman A. Smooth-muscle-specific gene transfer with the human maxi-k channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys. Eur Urol. 2009 Dec;56(6):1055-66. doi: 10.1016/j.eururo.2008.12.016. Epub 2008 Dec 25.
  • Syed Z, Scirica BM, Mohanavelu S, Sung P, Michelson EL, Cannon CP, Stone PH, Stultz CM, Guttag JV. Relation of death within 90 days of non-ST-elevation acute coronary syndromes to variability in electrocardiographic morphology. Am J Cardiol. 2009 Feb 1;103(3):307-11. doi: 10.1016/j.amjcard.2008.09.099. Epub 2008 Nov 19.
  • Olenchock BA, Fonarow GG, Pan W, Hernandez A, Cannon CP; Get With The Guidelines Steering Committee. Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes. Am J Cardiol. 2009 Feb 1;103(3):295-300. doi: 10.1016/j.amjcard.2008.09.081. Epub 2008 Nov 19.
  • Gilbert NF, Cannon CP, Lin PP, Lewis VO. Soft-tissue sarcoma. J Am Acad Orthop Surg. 2009 Jan;17(1):40-7. doi: 10.5435/00124635-200901000-00006.
  • Lai EJ, Calderwood AH, Doros G, Fix OK, Jacobson BC. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009 Mar;69(3 Pt 2):620-5. doi: 10.1016/j.gie.2008.05.057. Epub 2009 Jan 10.
  • Diercks DB, Kontos MC, Chen AY, Pollack CV Jr, Wiviott SD, Rumsfeld JS, Magid DJ, Gibler WB, Cannon CP, Peterson ED, Roe MT. Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry. J Am Coll Cardiol. 2009 Jan 13;53(2):161-6. doi: 10.1016/j.jacc.2008.09.030.
  • Coffman LG, Parsonage D, D’Agostino R Jr, Torti FM, Torti SV. Regulatory effects of ferritin on angiogenesis. Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):570-5. doi: 10.1073/pnas.0812010106. Epub 2009 Jan 6.
  • Norris AM, Gentry M, Peehl DM, D’Agostino R Jr, Scarpinato KD. The elevated expression of a mismatch repair protein is a predictor for biochemical recurrence after radical prostatectomy. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):57-64. doi: 10.1158/1055-9965.EPI-08-0377.
  • Hong JJ, Reynolds MR, Mattila TL, Hage A, Watkins DI, Miller CJ, Skinner PJ. Localized populations of CD8 MHC class I tetramer SIV-specific T cells in lymphoid follicles and genital epithelium. PLoS One. 2009;4(1):e4131. doi: 10.1371/journal.pone.0004131. Epub 2009 Jan 5.
  • Ray KK, Cannon CP, Cairns R, Morrow DA, Ridker PM, Braunwald E. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):424-30. doi: 10.1161/ATVBAHA.108.181735. Epub 2009 Jan 2.
  • Lewis WR, Fonarow GC, LaBresh KA, Cannon CP, Pan W, Super DM, Sorof SA, Schwamm LH. Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation. Am J Cardiol. 2009 Jan 15;103(2):227-31. doi: 10.1016/j.amjcard.2008.08.062. Epub 2008 Nov 7.
  • Bainey KR, Bhatt DL. Acute pericarditis: appendicitis of the heart?. Mayo Clin Proc. 2009;84(1):5-6. doi: 10.1016/S0025-6196(11)60799-4.
  • U’ren JM, Dalling JW, Gallery RE, Maddison DR, Davis EC, Gibson CM, Arnold AE. Diversity and evolutionary origins of fungi associated with seeds of a neotropical pioneer tree: a case study for analysing fungal environmental samples. Mycol Res. 2009 Apr;113(Pt 4):432-49. doi: 10.1016/j.mycres.2008.11.015. Epub 2008 Dec 13.
  • Fernandez AB, Keyes MJ, Pencina M, D’Agostino R, O’Donnell CJ, Thompson PD. Relation of corneal arcus to cardiovascular disease (from the Framingham Heart Study data set). Am J Cardiol. 2009 Jan 1;103(1):64-6. doi: 10.1016/j.amjcard.2008.08.030. Epub 2008 Oct 4.
  • Martin JL, Ellis SG, Colombo A, Grube E, Maloney T, Friedman MI, Baim DS, Dawkins K, Caputo R, Stone GW. Frequency of coronary artery bypass grafting following implantation of a paclitaxel-eluting or a bare-metal stent into a single coronary artery. Am J Cardiol. 2009 Jan 1;103(1):11-6. doi: 10.1016/j.amjcard.2008.08.025. Epub 2008 Oct 23.
  • Guy J, Ogden L, Wadwa RP, Hamman RF, Mayer-Davis EJ, Liese AD, D’Agostino R Jr, Marcovina S, Dabelea D. Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study. Diabetes Care. 2009 Mar;32(3):416-20. doi: 10.2337/dc08-1775. Epub 2008 Dec 17.
  • Sachdeva A, Cannon CP, Deedwania PC, Labresh KA, Smith SC Jr, Dai D, Hernandez A, Fonarow GC. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J. 2009 Jan;157(1):111-117.e2. doi: 10.1016/j.ahj.2008.08.010. Epub 2008 Oct 22.
  • Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, Ellrodt G, Cannon CP, Liang L, Peterson E, Labresh KA. Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2009 Jan 6;119(1):107-15. doi: 10.1161/CIRCULATIONAHA.108.783688. Epub 2008 Dec 15.
  • Scirica BM, Cannon CP, Sabatine MS, Jarolim P, Sloane S, Rifai N, Braunwald E, Morrow DA; PROVE IT-TIMI 22 Investigators. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death. Clin Chem. 2009 Feb;55(2):265-73. doi: 10.1373/clinchem.2008.117192. Epub 2008 Dec 12.
  • D’Agostino RB, Farewell V, Greenhouse JB, Whitehead J. Updating our aims and scope for the future. Stat Med. 2009 Jan 15;28(1):1-2. doi: 10.1002/sim.3502.
  • Matheny ME, Morrow DA, Ohno-Machado L, Cannon CP, Sabatine MS, Resnic FS. Validation of an automated safety surveillance system with prospective, randomized trial data. Med Decis Making. 2009 Mar-Apr;29(2):247-56. doi: 10.1177/0272989X08327110. Epub 2008 Nov 17.
  • Bainey KR, Jugdutt BI. Increased burden of coronary artery disease in South-Asians living in North America. Need for an aggressive management algorithm. Atherosclerosis. 2009 May;204(1):1-10. doi: 10.1016/j.atherosclerosis.2008.09.023. Epub 2008 Oct 1.
  • Lieb W, Pencina MJ, Lanier KJ, Tofler GH, Levy D, Fox CS, Wang TJ, D’Agostino RB Sr, Vasan RS. Association of parental obesity with concentrations of select systemic biomarkers in nonobese offspring: the Framingham Heart Study. Diabetes. 2009 Jan;58(1):134-7. doi: 10.2337/db08-0918. Epub 2008 Oct 17.
  • Charytan DM, Kuntz RE, Garshick M, Candia S, Khan MF, Mauri L. Location of acute coronary artery thromboses in patients with and without chronic kidney disease. Kidney Int. 2009 Jan;75(1):80-7. doi: 10.1038/ki.2008.480. Epub 2008 Sep 24.
  • Jiao Y, Wilkinson J 4th, Di X, Wang W, Hatcher H, Kock ND, D’Agostino R Jr, Knovich MA, Torti FM, Torti SV. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood. 2009 Jan 8;113(2):462-9. doi: 10.1182/blood-2008-05-155952. Epub 2008 Sep 24.
  • Kunadian V, Zorkun C, Gibson WJ, Nethala N, Harrigan C, Palmer AM, Ogando KJ, Biller LH, Lord EE, Williams SP, Lew ME, Ciaglo LN, Buros JL, Marble SJ, Gibson CM. Transfusion associated microchimerism: a heretofore little-recognized complication following transfusion. J Thromb Thrombolysis. 2009 Jan;27(1):57-67. doi: 10.1007/s11239-008-0268-0. Epub 2008 Sep 3.
  • Gibson CM, Hunter MS. Inherited fungal and bacterial endosymbionts of a parasitic wasp and its cockroach host. Microb Ecol. 2009 Apr;57(3):542-9. doi: 10.1007/s00248-008-9436-1. Epub 2008 Aug 31.
  • Murabito JM, Keyes MJ, Guo CY, Keaney JF Jr, Vasan RS, D’Agostino RB Sr, Benjamin EJ. Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study. Atherosclerosis. 2009 Apr;203(2):509-14. doi: 10.1016/j.atherosclerosis.2008.06.031. Epub 2008 Jul 9.
  • Gibson CM, Pride YB, Aylward PE, Col JJ, Goodman SG, Gulba D, Bergovec M, Kunadian V, Zorkun C, Buros JL, Murphy SA, Antman EM. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis. J Thromb Thrombolysis. 2009 Jan;27(1):11-7. doi: 10.1007/s11239-008-0264-4. Epub 2008 Aug 10.
  • Wylie JV Jr, Essebag V, Reynolds MR, Josephson ME. Inducibility of atrial fibrillation with a synchronized external low energy shock post-pulmonary vein isolation predicts recurrent atrial fibrillation. J Cardiovasc Electrophysiol. 2009 Jan;20(1):29-36. doi: 10.1111/j.1540-8167.2008.01264.x. Epub 2008 Apr 10.
  • Gristina R, D’Aloia E, Senesi GS, Milella A, Nardulli M, Sardella E, Favia P, d’Agostino R. Increasing cell adhesion on plasma deposited fluorocarbon coatings by changing the surface topography. J Biomed Mater Res B Appl Biomater. 2009 Jan;88(1):139-49. doi: 10.1002/jbm.b.31160.
  • Kunadian V, Harrigan C, Zorkun C, Palmer AM, Ogando KJ, Biller LH, Lord EE, Williams SP, Lew ME, Ciaglo LN, Buros JL, Marble SJ, Gibson WJ, Gibson CM. Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years. J Thromb Thrombolysis. 2009 Apr;27(3):316-28. doi: 10.1007/s11239-008-0220-3. Epub 2008 Apr 20.
  • Abraham JM, Gibson CM, Pena G, Sanz R, AlMahameed A, Murphy SA, Blanco J, Alonso-Briales J, Lopez-Mesa J, Gimeno F, Sánchez PL, Fernández-Avilés F; GRACIA-2 (Grupo de Análisis de la Cardiopatía Isquémica Aguda) Investigators. Association of angiographic perfusion score following percutaneous coronary intervention for ST-elevation myocardial infarction with left ventricular remodeling at 6 weeks in GRACIA-2. J Thromb Thrombolysis. 2009 Apr;27(3):253-8. doi: 10.1007/s11239-008-0206-1. Epub 2008 Mar 11.
  • Appelbaum E, Kirtane AJ, Clark A, Pride YB, Gelfand EV, Harrigan CJ, Kissinger KV, Manning WJ, Gibson CM. Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction. J Thromb Thrombolysis. 2009 Feb;27(2):123-9. doi: 10.1007/s11239-008-0197-y. Epub 2008 Feb 2.
  • Shea MK, Benjamin EJ, Dupuis J, Massaro JM, Jacques PF, D’Agostino RB Sr, Ordovas JM, O’Donnell CJ, Dawson-Hughes B, Vasan RS, Booth SL. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr. 2009 Apr;63(4):458-64. doi: 10.1038/sj.ejcn.1602959. Epub 2007 Nov 21.